At week @ , patients with JIA-American College of Rheumatology ( ACR ) @ improvement entered the @-week , double-blind part @ after randomisation @:@ to placebo or tocilizumab ( stratified by methotrexate and steroid background therapy ) for evaluation of the primary end point : JIA flare , compared with week @ .